Drug General Information
Drug ID
D09POH
Former ID
DIB004902
Drug Name
AEG-33773
Indication Diabetic neuropathy [ICD9: 250, 250.6, 356.0, 356.8; ICD10:E11.40] Phase 2 [522652]
Company
Aegera Therapeutics Inc
Target and Pathway
Target(s) Heat shock protein 70 Target Info Inhibitor [551193]
References
Ref 522652ClinicalTrials.gov (NCT00891683) Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy. U.S. National Institutes of Health.
Ref 551193Mitogen-activated protein kinase kinase kinase 12 (MAP3K12; DLK); c-jun N-terminal kinase (JNK). SciBX 2(11); doi:10.1038/scibx.2009.462. March 19 2009

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.